QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 organon-raises-fy2025-sales-guidance-from-6125b-6325b-to-6275b-6375b-vs-6223b-est

Organon (NYSE:OGN) raises FY2025 sales outlook from $6.125 billion-$6.325 billion to $6.275 billion-$6.375 billion vs $6.223 bi...

 organon-q2-adj-eps-100-beats-094-estimate-sales-1594b-beat-1552b-estimate

Organon (NYSE:OGN) reported quarterly earnings of $1.00 per share which beat the analyst consensus estimate of $0.94 by 6.84 pe...

 organons-phase-2-elena-proof-of-concept-study-of-og-6219-in-endometriosis-related-pain-did-not-meet-its-primary-efficacy-endpoint-discontinues-the-og-6219-clinical-development-program

Organon (NYSE:OGN), a global healthcare company with a focus on women's health, today announced that the Phase 2 ELENA proo...

 samsung-bioepis-and-organon-say-fda-designates-hadlima-high--and-low-concentration-autoinjectors-and-high-concentration-prefilled-syringe-as-interchangeable-biosimilars-to-humira

HADLIMA™ (adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL is now interchangeable with all high- and low-concentrati...

 piper-sandler-maintains-overweight-on-organon-lowers-price-target-to-18

Piper Sandler analyst David Amsellem maintains Organon (NYSE:OGN) with a Overweight and lowers the price target from $24 to ...

 morgan-stanley-maintains-equal-weight-on-organon-lowers-price-target-to-10

Morgan Stanley analyst Terence Flynn maintains Organon (NYSE:OGN) with a Equal-Weight and lowers the price target from $15 t...

 organons-board-of-directors-cuts-quarterly-dividend-to-002-per-share-down-from-028-per-share-company-resets-capital-allocation-priorities-to-accelerate-progress-towards-deleveraging-new-annual-regular-dividend-rate-of-008-per-share

 The dividend is payable on June 12, 2025, to stockholders of record at the close of business on May 12, 2025. 

 organon-affirms-fy2025-sales-guidance-of-613b-633b-vs-623b-est

Full year 2025 financial guidance is presented below on a non-GAAP basis, except revenue.  Previous Guidance as of February 13,...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION